Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment

18 Feb 2020

Abstract excerpt

Several studies have linked circulating cell-free mitochondrial DNA (ccf-mtDNA) to human disease. In particular, reduced ccf-mtDNA levels in the cerebrospinal fluid (CSF) of both Alzheimer's and Parkinson's disease (PD) patients have raised the hypothesis that ccf-mtDNA could be used as a biomarker for neurodegenerative disease onset and progression. However, how a reduction of CSF ccf-mtDNA levels relates to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Mitochondrial Function and Pathology
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32070373
DOI: 10.1186/s13024-020-00362-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentPMID 32070373Read ↗

Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early‐stage Parkinson's diseaseSemantic proximity Read ↗

Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative diseaseSemantic proximity Read ↗

A mitochondrial blood-based patient stratification candidate biomarker for Parkinson’s diseaseSemantic proximity Read ↗

Reduced mitochondrial DNA copy number is a biomarker of Parkinson's diseaseSemantic proximity Read ↗

A blood-based marker of mitochondrial DNA damage in Parkinson’s diseaseSemantic proximity Read ↗

Cell-free mitochondrial DNA in progressive multiple sclerosisSemantic proximity Read ↗

Longitudinal Changes in Mitochondrial DNA Copy Number and Telomere Length in Patients with Parkinson’s DiseaseSemantic proximity Read ↗

Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease.Semantic proximity Read ↗

Peripheral immune cell abundance differences link blood mitochondrial DNA copy number and Parkinson’s diseaseSemantic proximity Read ↗

Elevated serum mitochondrial DNA in females and lack of altered platelet mitochondrial methylation in patients with Parkinson´s diseaseSemantic proximity Read ↗

Mitochondrial DNA Copy Number as a Potential Biomarker for the Severity of Motor Symptoms and Prognosis in Parkinson's DiseaseSemantic proximity Read ↗

Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.